Publications in collaboration with researchers from University of Oxford (29)

2024

  1. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2022

  1. Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

    Seminars in Arthritis and Rheumatism, Vol. 56

  2. Treat-To-Target in rheumatoid arthritis: A real-world study of the application and impact of treat-To-Target within the wider context of patient management, patient centricity and advanced therapy use in Europe

    RMD Open, Vol. 8, Núm. 2

2021

  1. Secukinumab in patients with psoriatic arthritis and axial manifestations: Results from the double-blind, randomised, phase 3 MAXIMISE trial

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 5, pp. 582-590

  2. The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?

    Arthritis Care and Research, Vol. 73, Núm. 6, pp. 856-860

2019

  1. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

    Osteoarthritis and Cartilage, Vol. 27, Núm. 11, pp. 1578-1589

2018

  1. Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

    RMD Open, Vol. 4, Núm. 1

  2. Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

    Rheumatology and Therapy, Vol. 5, Núm. 2, pp. 567-582

  3. Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current european rheumatology practice

    Patient Preference and Adherence, Vol. 12, pp. 2007-2014

2016

  1. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 37-44

  2. Translation of clinical problems in osteoarthritis into pathophysiological research goals

    RMD Open, Vol. 2, Núm. 1

2015

  1. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 1, pp. 8-13

2014

  1. A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2130-2136

  2. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies

    Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949

  3. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2012

  1. Association of a BMP5 microsatellite with knee osteoarthritis: Case-control study

    Arthritis Research and Therapy, Vol. 14, Núm. 6

  2. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2011

  1. Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus

    Osteoarthritis and Cartilage, Vol. 19, Núm. 4, pp. 430-434

  2. Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 5, pp. 864-867